Which of the following is NOT a risk of intracavernosal injection of vasoactive agents?
A. PainAnswer D
Intracavernosal injection of vasoactive agents carries the risk of fibrosis, penile pain, prolonged erection, priapism and hematoma at the injection site. Fibrosis of the corpus cavernosum is a particular concern with papaverine.